Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients

Background Even in the era of highly active antiretroviral therapy (HAART), HIV-infected subjects are at higher risk of complications from vaccine-preventable diseases than those uninfected. The current international guidelines strongly recommend that these patients should receive all the routine ch...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Human vaccines & immunotherapeutics 2015-01, Vol.11 (1), p.263-269
Hauptverfasser:	Sticchi, Laura, Bruzzone, Bianca, Caligiuri, Patrizia, Rappazzo, Emanuela, Lo Casto, Michele, De Hoffer, Laura, Gustinetti, Giulia, Viscoli, Claudio, Di Biagio, Antonio
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Antibodies, Bacterial - blood Child Cross-Sectional Studies Diphtheria - immunology Enzyme-Linked Immunosorbent Assay Female Hepatitis A - immunology Hepatitis Antibodies - blood Hepatitis B - immunology HIV HIV Infections - complications Humans immunization coverage Male Neutralization Tests Poliomyelitis - immunology Research Paper routine immunization Seroepidemiologic Studies seroprevalence Tetanus - immunology Vaccination Vaccination - statistics & numerical data vaccine-preventable diseases Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!